Chemomab Therapeutics (CMMB) vs Jaguar Health (JAGX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Chemomab Therapeutics is the larger company by market cap ($10.3 million vs $8.8 million), about 1.2 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Head-to-head
| Metric | CMMB | JAGX |
|---|---|---|
| Share price | $1.41 | $4.51 |
| Market cap | $10.30M | $8.77M |
| 1-day change | +3.31% | -9.80% |
| YTD return | -16.97% | — |
| 1-year return | -60.69% | — |
| 5-year return | -96.23% | — |
| EPS (TTM) | $-1.04 | $-4,012.65 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $3.55 | $1,267.88 |
| 52-week low | $1.05 | $2.35 |
| Distance from 52-week high | -60.42% | -99.64% |
| Average volume | 118.53K | 2.00M |
| Shares outstanding | 7.33M | 1.95M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
CMMB vs JAGX FAQ
Which is bigger, Chemomab Therapeutics or Jaguar Health?
Chemomab Therapeutics (CMMB) is larger, with a market capitalization of $10.30M compared with $8.77M for Jaguar Health (JAGX).
Are Chemomab Therapeutics and Jaguar Health in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.